Regeneron Pharmaceuticals
REGN
REGN
437 hedge funds and large institutions have $20.9B invested in Regeneron Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 177 increasing their positions, 145 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
437
Holders Change
+23
Holders Change %
+5.56%
% of All Funds
12.69%
Holding in Top 10
7
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-46.15%
% of All Funds
0.2%
New
62
Increased
177
Reduced
145
Closed
38
Calls
$344M
Puts
$372M
Net Calls
-$28.6M
Net Calls Change
-$16.2M
Top Buyers
| 1 |
UBS AM
Chicago,
Illinois
|
+$180M |
| 2 |
DCP
DSM Capital Partners
Palm Beach Gardens,
Florida
|
+$99.9M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$88.1M |
| 4 |
O
OrbiMed
New York
|
+$62.1M |
| 5 |
Teacher Retirement System of Texas
Austin,
Texas
|
+$51.9M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$471M |
| 2 |
JPMorgan Chase & Co
New York
|
-$195M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$56.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$56.4M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$53.4M |
